PSA Screening Aids in Decreasing Prostate Cancer Death by 40 Percent
One in seven men in the U.S. will be diagnosed with prostate cancer at some point in their lifetime, and one in thirty-five men will die from the disease.
The Prostate-Specific Antigen (PSA) test, while not fool-proof, has been widely used to screen men for prostate cancer. Since doctors began PSA screening, the incidence of prostate cancer deaths has decreased by 40 percent.
The team of medical experts within the Florida Urology Partners network recommends that men between the ages of 50 to 70 who have a ten year life expectancy or greater should receive PSA screening.
It is especially important for African American men and men with a family history of the disease that fall within this age range to get screened, as they are at higher risk for developing prostate cancer.
Because prostate cancer is the most common cancer among men, building awareness about the disease and PSA screening is of utmost importance.